COHEN & STEERS CLOSED-END OP (FOF) Stock Price, Forecast & Analysis
USA - NYSE:FOF - US19248P1066
FOF Key Statistics, Chart & Performance
The current stock price of FOF is 12.9 USD. In the past month the price decreased by -1.15%. In the past year, price increased by 1.26%.
FOF Latest News, Press Relases and Analysis
COHEN & STEERS CLOSED-END OP / FOF FAQ
What does FOF do?
Cohen & Steers Closed End Opportunity Fund Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. The company went IPO on 2006-11-21. Cohen & Steers Closed-End Opportunity Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is to achieve a total return, consisting of high current income and potential capital appreciation. The company seeks to achieve its objective by investing in the common stock of closed-end management investment companies selected by the Fund’s investment manager that invest significantly in equity or income-producing securities. Its portfolio is focused on equity or income-producing securities, sectors or strategies, such as dividend strategies, covered call option strategies, total return strategies, balanced strategies, general equities (including both dividend and non-dividend paying equities), limited duration strategies, convertible securities, preferred securities, high yield securities and real estate, energy, utility and other equity or income-oriented strategies. The Fund’s investment manager is Cohen & Steers Capital Management, Inc.
Can you provide the latest stock price for COHEN & STEERS CLOSED-END OP?
The current stock price of FOF is 12.9 USD. The price decreased by -1.68% in the last trading session.
How is the ChartMill rating for COHEN & STEERS CLOSED-END OP?
FOF has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
FOF Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to FOF. When comparing the yearly performance of all stocks, FOF turns out to be only a medium performer in the overall market: it outperformed 41.34% of all stocks.